6 years of historical data (2019–2024) · Industrials · Staffing & Employment Services
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Kanzhun Limited trades at 27.6x earnings, 13% below its 5-year average of 31.9x, sitting at the 67th percentile of its historical range. Compared to the Industrials sector median P/E of 25.5x, the stock trades at a premium of 8%. On a free-cash-flow basis, the stock trades at 31.4x P/FCF, 302% above the 5-year average of 7.8x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Market Cap | $12.4B | $6.2B | $7.5B | $9.3B | $15.6B | — | — |
| Enterprise Value | $12.0B | $4.0B | $5.3B | $-166628811 | $4.6B | — | — |
| P/E Ratio → | 27.61 | 3.93 | 6.81 | 84.88 | — | — | — |
| P/S Ratio | 11.45 | 0.85 | 1.26 | 2.06 | 3.67 | — | — |
| P/B Ratio | 2.92 | 0.42 | 0.56 | 0.80 | 1.46 | — | — |
| P/FCF | 31.36 | 2.32 | 3.58 | 14.01 | 11.31 | — | — |
| P/OCF | 23.78 | 1.76 | 2.46 | 9.26 | 9.52 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Kanzhun Limited's enterprise value stands at 44.1x EBITDA, 1092% above its 5-year average of 3.7x. The Industrials sector median is 13.8x, placing the stock at a 221% premium on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.54 | 0.89 | -0.04 | 1.08 | — | — |
| EV / EBITDA | 44.10 | 2.14 | 5.26 | -1.06 | — | — | — |
| EV / EBIT | 69.90 | 3.39 | 9.13 | — | — | — | — |
| EV / FCF | — | 1.48 | 2.54 | -0.25 | 3.33 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Kanzhun Limited earns an operating margin of 15.9%, above the Industrials sector average of 4.9%. Operating margins have expanded from -2.9% to 15.9% over the past 3 years, signaling improving operational efficiency. ROE of 11.2% is modest. ROIC of 7.3% represents adequate returns on invested capital versus a sector median of 6.3%.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 83.1% | 83.1% | 82.2% | 83.3% | 87.0% | 87.6% | 86.2% |
| Operating Margin | 15.9% | 15.9% | 9.8% | -2.9% | -24.3% | -48.6% | -51.3% |
| Net Profit Margin | 21.5% | 21.5% | 18.5% | 2.4% | -25.1% | -48.2% | -50.3% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| ROE | 11.2% | 11.2% | 8.8% | 1.0% | -25.6% | — | — |
| ROA | 8.5% | 8.5% | 6.7% | 0.8% | -11.4% | -26.9% | -26.7% |
| ROIC | 7.3% | 7.3% | 6.5% | -10.6% | — | — | — |
| ROCE | 8.2% | 8.2% | 4.6% | -1.1% | -14.6% | -44.6% | -58.8% |
Solvency and debt-coverage ratios — lower is generally safer
Kanzhun Limited carries a Debt/EBITDA ratio of 0.2x, which is very conservative (95% below the sector average of 3.2x). The company holds a net cash position — cash of $2.6B exceeds total debt of $302M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | — | — |
| Debt / EBITDA | 0.16 | 0.16 | 0.28 | 1.87 | — | — | — |
| Net Debt / Equity | — | -0.15 | -0.16 | -0.81 | -1.03 | — | — |
| Net Debt / EBITDA | -1.21 | -1.21 | -2.17 | -59.90 | — | — | — |
| Debt / FCF | — | -0.84 | -1.05 | -14.27 | -7.98 | -14.99 | — |
| Interest Coverage | — | — | — | — | — | — | — |
Net cash position: cash ($2.6B) exceeds total debt ($302M)
Short-term solvency ratios and asset-utilisation metrics
Kanzhun Limited's current ratio of 3.60x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 4.56x to 3.60x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.60 | 3.60 | 3.07 | 4.56 | 4.65 | 2.76 | 1.69 |
| Quick Ratio | 3.60 | 3.60 | 3.02 | 4.47 | 4.65 | 2.76 | 1.61 |
| Cash Ratio | 3.50 | 3.50 | 2.96 | 4.36 | 4.39 | 2.64 | 1.54 |
| Asset Turnover | — | 0.38 | 0.33 | 0.30 | 0.31 | 0.38 | 0.53 |
| Inventory Turnover | 407.53 | 407.53 | 5.14 | 2.70 | — | — | 1.67 |
| Days Sales Outstanding | — | 10.17 | 1.03 | 0.80 | 35.28 | 22.89 | 27.61 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Kanzhun Limited returns 2.0% to shareholders annually primarily through share buybacks. The earnings yield of 3.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 7.5% | — | — | — | — |
| Payout Ratio | — | — | 51.2% | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.6% | 25.4% | 14.7% | 1.2% | — | — | — |
| FCF Yield | 3.2% | 43.1% | 27.9% | 7.1% | 8.8% | — | — |
| Buyback Yield | 2.0% | 26.5% | 1.0% | 9.9% | 0.1% | — | — |
| Total Shareholder Yield | 2.0% | 26.5% | 8.5% | 9.9% | 0.1% | — | — |
| Shares Outstanding | — | $451M | $451M | $456M | $448M | $458M | $458M |
Compare BZ with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $12B | 27.6 | 44.1 | 31.4 | 83.1% | 15.9% | 11.2% | 7.3% | 0.2 | |
| $2B | -7.5 | — | — | 96.0% | -156.3% | -63.3% | -64.1% | — | |
| $138M | -10.6 | 56.6 | 10.0 | 84.7% | -8.9% | -12.9% | -5.9% | 14.5 | |
| $1B | -104.9 | 9.0 | — | 16.7% | 1.3% | -0.6% | 5.6% | 7.4 | |
| $33B | 17.5 | 25.5 | 17.3 | 77.0% | 23.1% | 20.3% | 10.4% | 0.0 | |
| $1B | 12.8 | 9.7 | 5.7 | 77.8% | 16.4% | 19.1% | 14.3% | 2.5 | |
| $422M | 21.0 | 22.1 | 4.1 | 80.7% | -0.3% | 5.4% | -0.2% | 0.4 | |
| $573M | 5.8 | 3.3 | 7.8 | 32.6% | 11.9% | 18.6% | 16.3% | 1.5 | |
| $5B | 73.5 | 42.0 | 16.2 | 57.1% | 5.0% | 8.9% | 14.2% | 2.1 | |
| $49B | 14.4 | 10.8 | 25.4 | 50.3% | 16.0% | 8.7% | 4.8% | 2.2 | |
| $340B | 17.9 | 13.6 | 29.6 | 40.0% | 14.1% | 11.8% | 9.6% | 1.4 | |
| Industrials Median | — | 25.5 | 13.8 | 20.7 | 32.7% | 4.9% | 8.2% | 6.3% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 6 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Arcus Biosciences, Inc..
Start ComparisonQuick answers to the most common questions about buying BZ stock.
Kanzhun Limited's current P/E ratio is 27.6x. The historical average is 31.9x. This places it at the 67th percentile of its historical range.
Kanzhun Limited's current EV/EBITDA is 44.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 3.7x.
Kanzhun Limited's return on equity (ROE) is 11.2%. The historical average is -1.2%.
Based on historical data, Kanzhun Limited is trading at a P/E of 27.6x. This is at the 67th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Kanzhun Limited has 83.1% gross margin and 15.9% operating margin. Operating margin between 10-20% is typical for established companies.
Kanzhun Limited's Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.